Literature DB >> 17882722

Isolation of early hematopoietic cells, including megakaryocyte progenitors, in the ALDH-bright cell population of cryopreserved, banked UC blood.

T Gentry1, E Deibert, S J Foster, R Haley, J Kurtzberg, A E Balber.   

Abstract

BACKGROUND: ALDH-bright (ALDH(br)) cell populations sorted from freshly collected umbilical cord blood (UCB) on the basis of their high aldehyde dehydrogenase (ALDH) activity are highly enriched for HPC. HPC with low ALDH activity (ALDH(dim)) are primarily short-term progenitors, whereas progenitors that initiate long-term cultures or establish long-term grafts in xenograft models are ALDH(br). We examined the multilineage hematopoietic and platelet progenitor activities of ALDH(br) cells recovered from cryopreserved UCB units typically employed in the practice of clinical transplantation.
METHODS: Frozen UCB units were thawed, washed, immunomagnetically depleted of cells expressing glycophorin A and CD14, reacted for flow cytometric detection of ALDH, and sorted to yield ALDH(br) and ALDH(dim) populations. We measured surface Ag expression and viability of cells in the ALDH(br) and ALDH(dim) populations by flow cytometry and hematopoietic (CFC-H) and megakaryocytic (CFC-Mk) colony-forming cells in each population.
RESULTS: ALDH(br) populations isolated from thawed UCB cells were highly enriched for CD34(+) and CD133(+) cells. Flow-sorted ALDH(br) populations were enriched 1116-fold in CFC-H, 10-fold in multilineage GEMM colonies and 2015-fold in CFC-Mk compared with the ALDH(dim) population. All progenitors giving rise to large Mk colonies were derived from ALDH(br) populations. DISCUSSION: ALDH(br) populations recovered from thawed, banked UCB with the method we describe have HPC activity and may be useful in the clinic to facilitate reconstitution of erythroid, myeloid and megakaryocytic blood elements.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17882722     DOI: 10.1080/14653240701466347

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  17 in total

1.  Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.

Authors:  Ines A Silva; Shoumei Bai; Karen McLean; Kun Yang; Kent Griffith; Dafydd Thomas; Christophe Ginestier; Carolyn Johnston; Angela Kueck; R Kevin Reynolds; Max S Wicha; Ronald J Buckanovich
Journal:  Cancer Res       Date:  2011-04-15       Impact factor: 12.701

Review 2.  Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions.

Authors:  Santosh K Sanganalmath; Roberto Bolli
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

3.  Aldehyde dehydrogenase activity identifies a population of human skeletal muscle cells with high myogenic capacities.

Authors:  Karine Vauchez; Jean-Pierre Marolleau; Michel Schmid; Patricia Khattar; Alain Chapel; Cyril Catelain; Séverine Lecourt; Jérôme Larghéro; Marc Fiszman; Jean-Thomas Vilquin
Journal:  Mol Ther       Date:  2009-09-08       Impact factor: 11.454

4.  Clinical-scale in vitro expansion preserves biological characteristics of cardiac atrial appendage stem cells.

Authors:  S Windmolders; L Willems; A Daniëls; L Linsen; Y Fanton; M Hendrikx; R Koninckx; J-L Rummens; K Hensen
Journal:  Cell Prolif       Date:  2015-01-29       Impact factor: 6.831

5.  Endothelial Progenitor Cell Levels Predict Future Physical Function: An Exploratory Analysis From the VA Enhanced Fitness Study.

Authors:  Thomas J Povsic; Richard Sloane; Carl F Pieper; Megan P Pearson; Eric D Peterson; Harvey J Cohen; Miriam C Morey
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-10-28       Impact factor: 6.053

6.  Aging is not associated with bone marrow-resident progenitor cell depletion.

Authors:  Thomas J Povsic; Jiying Zhou; Stacie D Adams; Michael P Bolognesi; David E Attarian; Eric D Peterson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-06-30       Impact factor: 6.053

7.  Development and validation of a rapid, aldehyde dehydrogenase bright-based cord blood potency assay.

Authors:  Kevin Shoulars; Pamela Noldner; Jesse D Troy; Lynn Cheatham; Amanda Parrish; Kristin Page; Tracy Gentry; Andrew E Balber; Joanne Kurtzberg
Journal:  Blood       Date:  2016-03-11       Impact factor: 22.113

Review 8.  Ovarian cancer stem cell markers: prognostic and therapeutic implications.

Authors:  Daniela Burgos-Ojeda; Bo R Rueda; Ronald J Buckanovich
Journal:  Cancer Lett       Date:  2012-02-11       Impact factor: 8.679

9.  Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metabolic diseases.

Authors:  Joanne Kurtzberg; Susan Buntz; Tracy Gentry; Pamela Noeldner; April Ozamiz; Benjamin Rusche; Robert W Storms; Amy Wollish; David A Wenger; Andrew E Balber
Journal:  Cytotherapy       Date:  2015-03-12       Impact factor: 5.414

10.  Lower levels of circulating progenitor cells are associated with low physical function and performance in elderly men with impaired glucose tolerance: a pilot substudy from the VA Enhanced Fitness trial.

Authors:  Thomas J Povsic; Richard Sloane; Jiying Zhou; Carl F Pieper; Megan P Pearson; Eric D Peterson; Jennifer B Green; Harvey J Cohen; Miriam C Morey
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-05-16       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.